Among known adhesion molecules, including VCAM1/VLA-4, CD40/CD40L, and MUC1/ICAM1 [12], we identified that CD40/CD40L signaling acts as the bridge between BMSCs and MM cells, sensitizing MM cells to ferroptosis-based-therapy by promoting iron accumulation. Here, CD40 is linked to Miyoshi myopathy.